GOLDMAN SACHS GROUP INC - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 164 filers reported holding DICE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.30 and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$33,313,632
+637.7%
717,039
+354.9%
0.01%
+600.0%
Q1 2023$4,515,727
-15.4%
157,617
-7.8%
0.00%0.0%
Q4 2022$5,335,418
+621019.7%
171,007
+303.7%
0.00%
Q3 2022$859
+290.5%
42,361
+199.4%
0.00%
Q2 2022$220
-99.9%
14,150
+8.6%
0.00%
Q1 2022$249,000
-80.5%
13,035
-66.6%
0.00%
Q3 2021$1,277,00039,0000.00%
Other shareholders

There were no reported owners of DICE THERAPEUTICS INC in Q2 2023.

NameSharesValueWeighting ↓
View complete list of DICE THERAPEUTICS INC shareholders